Vav Lipids Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 1.70 Cr
as on 16-11-2024
- Company Age 15 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.81 Cr
as on 16-11-2024
- Satisfied Charges ₹ 11.47 Cr
as on 16-11-2024
- Revenue 115.41%
(FY 2023)
- Profit 794.09%
(FY 2023)
- Ebitda 910.32%
(FY 2023)
- Net Worth 40.22%
(FY 2023)
- Total Assets 26.64%
(FY 2023)
About Vav Lipids
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.70 Cr.
The company currently has active open charges totaling ₹6.81 Cr. The company has closed loans amounting to ₹11.47 Cr, as per Ministry of Corporate Affairs (MCA) records.
Arun Kedia, Hareesh Tibrewala, Rahul Nandre, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24100MH2009PTC190024
- Company No.
190024
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Feb 2009
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Vav Lipids?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arun Kedia  | Director | 02-Feb-2009 | Current |
| Hareesh Tibrewala | Director | 07-Jun-2024 | Current |
| Rahul Nandre | Director | 15-Feb-2019 | Current |
| Pranav Kedia | Director | 20-Jan-2021 | Current |
| Sabita Kedia | Director | 02-Feb-2009 | Current |
Financial Performance of Vav Lipids.
Vav Lipids Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 115.41% increase. The company also saw a substantial improvement in profitability, with a 794.09% increase in profit. The company's net worth Soared by an impressive increase of 40.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vav Lipids?
In 2023, Vav Lipids had a promoter holding of 93.98% and a public holding of 6.03%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vav Life Sciences Private LimitedActive 21 years 11 monthsArun Kedia and Sabita Kedia are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Sidbi Creation Date: 30 Dec 2021 | ₹4.10 M | Open |
Others Creation Date: 07 Jul 2021 | ₹6.40 Cr | Open |
Axis Bank Limited Creation Date: 01 Dec 2021 | ₹2.65 Cr | Satisfied |
How Many Employees Work at Vav Lipids?
Vav Lipids has a workforce of 40 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vav Lipids, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vav Lipids's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
